How big is the enbrel etanercept biosimilar market?

It is a biologic fusion protein in the TNF blocker class of medications.According to QYResearchs new survey global Enbrel Etanercept Biosimilar market is projected to reach US 1707.3 million in 2029 increasing from US 1247 million in 2022 with the CAGR of 4.6 during the period of 2023 to 2029.

Who are the key players in the enbrel etanercept biosimilar market?

Some of the key players are Key, Novartis, Novartis AG, SAMSUNG, Lupin Ltd, Others.

Global Enbrel Etanercept Biosimilar Market Research Report 2023

BUY CHAPTERS

Global Enbrel (Etanercept) and Biosimilar Market Research Report 2023

Code: QYRE-Auto-33H14580

Report

June 2023

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Enbrel (Etanercept) and Biosimilar Market Size

According to QYResearch’s new survey, global Enbrel (Etanercept) and Biosimilar market is projected to reach US$ 8562.6 million in 2029, increasing from US$ 6350 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2029.

Enbrel (Etanercept) and Biosimilar Market

Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Enbrel (Etanercept) and Biosimilar market research.

Key manufacturers engaged in the Enbrel (Etanercept) and Biosimilar industry include Pfizer, Amgen, Samsung Bioepis, Novartis, 3s Bio and Lupin, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Enbrel (Etanercept) and Biosimilar were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Enbrel (Etanercept) and Biosimilar market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Enbrel (Etanercept) and Biosimilar market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Enbrel (Etanercept) and Biosimilar Market Report

Report Metric	Details
Report Name	Enbrel (Etanercept) and Biosimilar Market
Accounted market size in 2022	US$ 6350 million
Forecasted market size in 2029	US$ 8562.6 million
CAGR	3.3%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Syringe Pen
Segment by Application	Hospital Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Amgen, Samsung Bioepis, Novartis, 3s Bio, Lupin
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Enbrel (Etanercept) and Biosimilar Market market growing?

Ans: The Enbrel (Etanercept) and Biosimilar Market market witnessing a CAGR of 3.3% during the forecast period 2023-2029.

What is the Enbrel (Etanercept) and Biosimilar Market market size in 2029?

Ans: According to QYResearch’s new survey, global Enbrel (Etanercept) and Biosimilar market is projected to reach US$ 8562.6 million in 2029, increasing from US$ 6350 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2029.

1 Enbrel (Etanercept) and Biosimilar Market Overview

1.1 Product Overview and Scope of Enbrel (Etanercept) and Biosimilar

1.2 Enbrel (Etanercept) and Biosimilar Segment by Type

1.2.1 Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Type (2023-2029)

1.2.2 Syringe

1.2.3 Pen

1.3 Enbrel (Etanercept) and Biosimilar Segment by Application

1.3.1 Global Enbrel (Etanercept) and Biosimilar Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Enbrel (Etanercept) and Biosimilar Market Size Estimates and Forecasts

1.4.1 Global Enbrel (Etanercept) and Biosimilar Revenue 2018-2029

1.4.2 Global Enbrel (Etanercept) and Biosimilar Sales 2018-2029

1.4.3 Global Enbrel (Etanercept) and Biosimilar Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2 Enbrel (Etanercept) and Biosimilar Market Competition by Manufacturers

2.1 Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Manufacturers (2018-2023)

2.2 Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Manufacturers (2018-2023)

2.4 Global Enbrel (Etanercept) and Biosimilar Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Product Type & Application

2.7 Enbrel (Etanercept) and Biosimilar Market Competitive Situation and Trends

2.7.1 Enbrel (Etanercept) and Biosimilar Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Enbrel (Etanercept) and Biosimilar Players Market Share by Revenue

2.7.3 Global Enbrel (Etanercept) and Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Enbrel (Etanercept) and Biosimilar Retrospective Market Scenario by Region

3.1 Global Enbrel (Etanercept) and Biosimilar Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Enbrel (Etanercept) and Biosimilar Global Enbrel (Etanercept) and Biosimilar Sales by Region: 2018-2029

3.2.1 Global Enbrel (Etanercept) and Biosimilar Sales by Region: 2018-2023

3.2.2 Global Enbrel (Etanercept) and Biosimilar Sales by Region: 2024-2029

3.3 Global Enbrel (Etanercept) and Biosimilar Global Enbrel (Etanercept) and Biosimilar Revenue by Region: 2018-2029

3.3.1 Global Enbrel (Etanercept) and Biosimilar Revenue by Region: 2018-2023

3.3.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Region: 2024-2029

3.4 North America Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country

3.4.1 North America Enbrel (Etanercept) and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2029)

3.4.3 North America Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country

3.5.1 Europe Enbrel (Etanercept) and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2029)

3.5.3 Europe Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country

3.6.1 Asia Pacific Enbrel (Etanercept) and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2029)

3.6.3 Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country

3.7.1 Latin America Enbrel (Etanercept) and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2029)

3.7.3 Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Enbrel (Etanercept) and Biosimilar Market Facts & Figures by Country

3.8.1 Middle East and Africa Enbrel (Etanercept) and Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2029)

3.8.3 Middle East and Africa Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Enbrel (Etanercept) and Biosimilar Sales by Type (2018-2029)

4.1.1 Global Enbrel (Etanercept) and Biosimilar Sales by Type (2018-2023)

4.1.2 Global Enbrel (Etanercept) and Biosimilar Sales by Type (2024-2029)

4.1.3 Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Type (2018-2029)

4.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Type (2018-2029)

4.2.1 Global Enbrel (Etanercept) and Biosimilar Revenue by Type (2018-2023)

4.2.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Type (2024-2029)

4.2.3 Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Type (2018-2029)

4.3 Global Enbrel (Etanercept) and Biosimilar Price by Type (2018-2029)

5 Segment by Application

5.1 Global Enbrel (Etanercept) and Biosimilar Sales by Application (2018-2029)

5.1.1 Global Enbrel (Etanercept) and Biosimilar Sales by Application (2018-2023)

5.1.2 Global Enbrel (Etanercept) and Biosimilar Sales by Application (2024-2029)

5.1.3 Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Application (2018-2029)

5.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Application (2018-2029)

5.2.1 Global Enbrel (Etanercept) and Biosimilar Revenue by Application (2018-2023)

5.2.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Application (2024-2029)

5.2.3 Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Application (2018-2029)

5.3 Global Enbrel (Etanercept) and Biosimilar Price by Application (2018-2029)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Pfizer Enbrel (Etanercept) and Biosimilar Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Amgen

6.2.1 Amgen Corporation Information

6.2.2 Amgen Description and Business Overview

6.2.3 Amgen Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Amgen Enbrel (Etanercept) and Biosimilar Product Portfolio

6.2.5 Amgen Recent Developments/Updates

6.3 Samsung Bioepis

6.3.1 Samsung Bioepis Corporation Information

6.3.2 Samsung Bioepis Description and Business Overview

6.3.3 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product Portfolio

6.3.5 Samsung Bioepis Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Corporation Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Novartis Enbrel (Etanercept) and Biosimilar Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 3s Bio

6.5.1 3s Bio Corporation Information

6.5.2 3s Bio Description and Business Overview

6.5.3 3s Bio Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.5.4 3s Bio Enbrel (Etanercept) and Biosimilar Product Portfolio

6.5.5 3s Bio Recent Developments/Updates

6.6 Lupin

6.6.1 Lupin Corporation Information

6.6.2 Lupin Description and Business Overview

6.6.3 Lupin Enbrel (Etanercept) and Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Lupin Enbrel (Etanercept) and Biosimilar Product Portfolio

6.6.5 Lupin Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Enbrel (Etanercept) and Biosimilar Industry Chain Analysis

7.2 Enbrel (Etanercept) and Biosimilar Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enbrel (Etanercept) and Biosimilar Production Mode & Process

7.4 Enbrel (Etanercept) and Biosimilar Sales and Marketing

7.4.1 Enbrel (Etanercept) and Biosimilar Sales Channels

7.4.2 Enbrel (Etanercept) and Biosimilar Distributors

7.5 Enbrel (Etanercept) and Biosimilar Customers

8 Enbrel (Etanercept) and Biosimilar Market Dynamics

8.1 Enbrel (Etanercept) and Biosimilar Industry Trends

8.2 Enbrel (Etanercept) and Biosimilar Market Drivers

8.3 Enbrel (Etanercept) and Biosimilar Market Challenges

8.4 Enbrel (Etanercept) and Biosimilar Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Type (2023-2029) & (US$ Million)

Table 2. Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Application (2023-2029) & (US$ Million)

Table 3. Global Enbrel (Etanercept) and Biosimilar Market Competitive Situation by Manufacturers in 2022

Table 4. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) of Key Manufacturers (2018-2023)

Table 5. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Manufacturers (2018-2023)

Table 6. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Manufacturers (2018-2023)

Table 7. Global Enbrel (Etanercept) and Biosimilar Revenue Share by Manufacturers (2018-2023)

Table 8. Global Market Enbrel (Etanercept) and Biosimilar Average Price (US$/Unit) of Key Manufacturers (2018-2023)

Table 9. Global Key Players of Enbrel (Etanercept) and Biosimilar, Industry Ranking, 2021 VS 2022 VS 2023

Table 10. Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Product Type & Application

Table 12. Global Key Manufacturers of Enbrel (Etanercept) and Biosimilar, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Enbrel (Etanercept) and Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enbrel (Etanercept) and Biosimilar as of 2022)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Enbrel (Etanercept) and Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 17. Global Enbrel (Etanercept) and Biosimilar Sales by Region (2018-2023) & (K Units)

Table 18. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Region (2018-2023)

Table 19. Global Enbrel (Etanercept) and Biosimilar Sales by Region (2024-2029) & (K Units)

Table 20. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Region (2024-2029)

Table 21. Global Enbrel (Etanercept) and Biosimilar Revenue by Region (2018-2023) & (US$ Million)

Table 22. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Region (2018-2023)

Table 23. Global Enbrel (Etanercept) and Biosimilar Revenue by Region (2024-2029) & (US$ Million)

Table 24. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Region (2024-2029)

Table 25. North America Enbrel (Etanercept) and Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 26. North America Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2023) & (K Units)

Table 27. North America Enbrel (Etanercept) and Biosimilar Sales by Country (2024-2029) & (K Units)

Table 28. North America Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2023) & (US$ Million)

Table 29. North America Enbrel (Etanercept) and Biosimilar Revenue by Country (2024-2029) & (US$ Million)

Table 30. Europe Enbrel (Etanercept) and Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 31. Europe Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2023) & (K Units)

Table 32. Europe Enbrel (Etanercept) and Biosimilar Sales by Country (2024-2029) & (K Units)

Table 33. Europe Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2023) & (US$ Million)

Table 34. Europe Enbrel (Etanercept) and Biosimilar Revenue by Country (2024-2029) & (US$ Million)

Table 35. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 36. Asia Pacific Enbrel (Etanercept) and Biosimilar Sales by Region (2018-2023) & (K Units)

Table 37. Asia Pacific Enbrel (Etanercept) and Biosimilar Sales by Region (2024-2029) & (K Units)

Table 38. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Region (2018-2023) & (US$ Million)

Table 39. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue by Region (2024-2029) & (US$ Million)

Table 40. Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 41. Latin America Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2023) & (K Units)

Table 42. Latin America Enbrel (Etanercept) and Biosimilar Sales by Country (2024-2029) & (K Units)

Table 43. Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2023) & (US$ Million)

Table 44. Latin America Enbrel (Etanercept) and Biosimilar Revenue by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Enbrel (Etanercept) and Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 46. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales by Country (2018-2023) & (K Units)

Table 47. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales by Country (2024-2029) & (K Units)

Table 48. Middle East & Africa Enbrel (Etanercept) and Biosimilar Revenue by Country (2018-2023) & (US$ Million)

Table 49. Middle East & Africa Enbrel (Etanercept) and Biosimilar Revenue by Country (2024-2029) & (US$ Million)

Table 50. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Type (2018-2023)

Table 51. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Type (2024-2029)

Table 52. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Type (2018-2023)

Table 53. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Type (2024-2029)

Table 54. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Type (2018-2023)

Table 55. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Type (2024-2029)

Table 56. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Type (2018-2023)

Table 57. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Type (2024-2029)

Table 58. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Type (2018-2023)

Table 59. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Type (2024-2029)

Table 60. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Application (2018-2023)

Table 61. Global Enbrel (Etanercept) and Biosimilar Sales (K Units) by Application (2024-2029)

Table 62. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Application (2018-2023)

Table 63. Global Enbrel (Etanercept) and Biosimilar Sales Market Share by Application (2024-2029)

Table 64. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Application (2018-2023)

Table 65. Global Enbrel (Etanercept) and Biosimilar Revenue (US$ Million) by Application (2024-2029)

Table 66. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Application (2018-2023)

Table 67. Global Enbrel (Etanercept) and Biosimilar Revenue Market Share by Application (2024-2029)

Table 68. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Application (2018-2023)

Table 69. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Application (2024-2029)

Table 70. Pfizer Corporation Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 73. Pfizer Enbrel (Etanercept) and Biosimilar Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Amgen Corporation Information

Table 76. Amgen Description and Business Overview

Table 77. Amgen Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 78. Amgen Enbrel (Etanercept) and Biosimilar Product

Table 79. Amgen Recent Developments/Updates

Table 80. Samsung Bioepis Corporation Information

Table 81. Samsung Bioepis Description and Business Overview

Table 82. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 83. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product

Table 84. Samsung Bioepis Recent Developments/Updates

Table 85. Novartis Corporation Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 88. Novartis Enbrel (Etanercept) and Biosimilar Product

Table 89. Novartis Recent Developments/Updates

Table 90. 3s Bio Corporation Information

Table 91. 3s Bio Description and Business Overview

Table 92. 3s Bio Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 93. 3s Bio Enbrel (Etanercept) and Biosimilar Product

Table 94. 3s Bio Recent Developments/Updates

Table 95. Lupin Corporation Information

Table 96. Lupin Description and Business Overview

Table 97. Lupin Enbrel (Etanercept) and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 98. Lupin Enbrel (Etanercept) and Biosimilar Product

Table 99. Lupin Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Enbrel (Etanercept) and Biosimilar Distributors List

Table 103. Enbrel (Etanercept) and Biosimilar Customers List

Table 104. Enbrel (Etanercept) and Biosimilar Market Trends

Table 105. Enbrel (Etanercept) and Biosimilar Market Drivers

Table 106. Enbrel (Etanercept) and Biosimilar Market Challenges

Table 107. Enbrel (Etanercept) and Biosimilar Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Enbrel (Etanercept) and Biosimilar

Figure 2. Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Type (2023-2029) & (US$ Million)

Figure 3. Global Enbrel (Etanercept) and Biosimilar Market Share by Type in 2022 & 2029

Figure 4. Syringe Product Picture

Figure 5. Pen Product Picture

Figure 6. Global Enbrel (Etanercept) and Biosimilar Market Value Comparison by Application (2023-2029) & (US$ Million)

Figure 7. Global Enbrel (Etanercept) and Biosimilar Market Share by Application in 2022 & 2029

Figure 8. Hospital

Figure 9. Pharmacy

Figure 10. Other

Figure 11. Global Enbrel (Etanercept) and Biosimilar Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 12. Global Enbrel (Etanercept) and Biosimilar Market Size (2018-2029) & (US$ Million)

Figure 13. Global Enbrel (Etanercept) and Biosimilar Sales (2018-2029) & (K Units)

Figure 14. Global Enbrel (Etanercept) and Biosimilar Average Price (US$/Unit) & (2018-2029)

Figure 15. Enbrel (Etanercept) and Biosimilar Report Years Considered

Figure 16. Enbrel (Etanercept) and Biosimilar Sales Share by Manufacturers in 2022

Figure 17. Global Enbrel (Etanercept) and Biosimilar Revenue Share by Manufacturers in 2022

Figure 18. The Global 5 and 10 Largest Enbrel (Etanercept) and Biosimilar Players: Market Share by Revenue in 2022

Figure 19. Enbrel (Etanercept) and Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 20. Global Enbrel (Etanercept) and Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Figure 21. North America Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2018-2029)

Figure 22. North America Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2018-2029)

Figure 23. United States Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 24. Canada Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 25. Europe Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2018-2029)

Figure 26. Europe Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2018-2029)

Figure 27. Germany Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 28. France Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 29. U.K. Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 30. Italy Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 31. Russia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 32. Asia Pacific Enbrel (Etanercept) and Biosimilar Sales Market Share by Region (2018-2029)

Figure 33. Asia Pacific Enbrel (Etanercept) and Biosimilar Revenue Market Share by Region (2018-2029)

Figure 34. China Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 35. Japan Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 36. South Korea Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 37. India Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 38. Australia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 39. China Taiwan Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 40. Southeast Asia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 41. Latin America Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2018-2029)

Figure 42. Latin America Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2018-2029)

Figure 43. Mexico Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 44. Brazil Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 45. Argentina Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 46. Colombia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 47. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Market Share by Country (2018-2029)

Figure 48. Middle East & Africa Enbrel (Etanercept) and Biosimilar Revenue Market Share by Country (2018-2029)

Figure 49. Turkey Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 50. Saudi Arabia Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 51. UAE Enbrel (Etanercept) and Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 52. Global Sales Market Share of Enbrel (Etanercept) and Biosimilar by Type (2018-2029)

Figure 53. Global Revenue Market Share of Enbrel (Etanercept) and Biosimilar by Type (2018-2029)

Figure 54. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Type (2018-2029)

Figure 55. Global Sales Market Share of Enbrel (Etanercept) and Biosimilar by Application (2018-2029)

Figure 56. Global Revenue Market Share of Enbrel (Etanercept) and Biosimilar by Application (2018-2029)

Figure 57. Global Enbrel (Etanercept) and Biosimilar Price (US$/Unit) by Application (2018-2029)

Figure 58. Enbrel (Etanercept) and Biosimilar Value Chain

Figure 59. Enbrel (Etanercept) and Biosimilar Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Enbrel (Etanercept) and Biosimilar Market Research Report 2023

Published Date: June 2023

Report Code: QYRE-Auto-33H14580

Global Enbrel (Etanercept) and Biosimilar Market Research Report 2023

FEATURED COMPANIES

Enbrel (Etanercept) and Biosimilar Market Size

Enbrel (Etanercept) and Biosimilar Market

Report Scope

Scope of Enbrel (Etanercept) and Biosimilar Market Report

FAQ for this report

How fast is Enbrel (Etanercept) and Biosimilar Market market growing?

What is the Enbrel (Etanercept) and Biosimilar Market market size in 2029?

FEATURED COMPANIES